|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Pemetrexed
Making Science Personal: Lilly Oncology to Unveil 76 Studies at ... - May 23, 2007 campus med,The company will present important data on GEMZAR(R) (gemcitabine HCl for injection), ALIMTA(R) (pemetrexed for injection), and enzastaurin,
UK Lags Behind In New Cancer Drug Uptake And Survival - May 11, 2007 Medical News Today,..."The greatest differences in uptake were noted for the new colorectal and lung cancer drugs: bevacizumab, cetuximab, erlotinib and pemetrexed."
Firm OK's interim analysis of cancer study - May 15, 2007 Boston Globe,...pharmaceutical company said its board approved an analysis on the Phase 3 non-small cell lung cancer study of talabostat in combination with pemetrexed.
World face inequalities in access to cancer treatment - May 10, 2007 SpiritIndia,For pemetrexed, France and the USA had a high uptake and Canada, Czech Republic, New Zealand, Poland and the UK had a low uptake.
Asbestos sufferers denied drugs to ease pain - May 10, 2007 Portsmouth News,The drug – also called Pemetrexed – costs up to £30000 per patient and is prescribed in other asbestos hotspots including Liverpool, Newcastle and Scotland.
NZ lags in access to life-saving drugs - May 9, 2007 TVNZ,Erbitux, or cetuximab; Tarceva, or erlotinib; and Alimta, or pemetrexed. The uptake of Avastin for colorectal cancer in the United States, for example,
Experts warn of global gulf in cancer treatment - May 9, 2007 Reuters...seen in four new colorectal and lung cancer drugs -- Avastin, or bevacizumab; Erbitux, or cetuximab; Tarceva, or erlotinib; and Alimta, or pemetrexed.
Point Thera puts talabostat trial on hold - May 21, 2007 MarketWatchThe other study tested the effectiveness of talabostat in combination with lung-cancer drug Alimta, or pemetrexed. "We are obviously surprised and
Lung Cancer is the Third Most Common Malignant Disease and the ... - May 13, 2007 Fuerteventura Digital,Lately gefitinib, pemetrexed and erlotinib have entered the market and are initially used in second or third-line treatments.
NZ has slow uptake of new cancer drugs - May 10, 2007 Stuff.co.nz,New Zealand was mentioned particularly for having a low level of uptake of the drug pemetrexed, which was registered for use in New Zealand three years ago
Report finds "low and slow" uptake of new anticancers in UK - May 11, 2007 Pharma Times (subscription),Roche), cetuximab (Erbitux, Bristol-Myers Squibb/Merck KGaA), erlotnib (Tarceva, OSI Pharmaceuticals/Roche) and pemetrexed (Alimta, Eli Lilly.
Australian scientists directly target cancer cells - May 11, 2007 People's Daily Online,...were seen in four new colorectal and lung cancer drugs Avastin, or bevacizumab; Erbitux, or cetuximab; Tarceva, or erlotinib; and Alimta, or pemetrexed.
Experts warn of global gap in cancer treatment - May 10, 2007 Scientific American...seen in four new colorectal and lung cancer drugs - bevacizumab (Avastin); cetuximab (Erbitux); erlotinib (Tarceva); (Alimta); or pemetrexed (Alimta).
‘Stark inequalities’ in access to cancer drugs - May 9, 2007 MSNBC...seen in four new colorectal and lung cancer drugs — Avastin, or bevacizumab; Erbitux, or cetuximab; Tarceva, or erlotinib; and Alimta, or pemetrexed.
Eli Lilly's profits take a tumble - Apr 17, 2007 Pharma Times (subscription),...and cancer treatments Gemzar (gemcitabine) and Alimta (pemetrexed), as well as consistent growth for its schizophrenia drug Zyprexa (olanzapine).
Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting - Apr 17, 2007 Drug Newswire (press release),Many of the studies -- which investigate ALIMTA(R) (pemetrexed for injection); GEMZAR(R) (gemcitabine HCl for injection), enzastaurin and other products in
Cancer drug block blow - Apr 2, 2007 York Press,...(NICE) - which provides guidance on treating ill-health - said it did not recommend pemetrexed disodium (Alimta) as an effective use of NHS resources.
Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales ... - Apr 16, 2007 Earthtimes.orgActos(R) (pioglitazone hydrochloride, Takeda) Alimta(R) (pemetrexed, Lilly) Arxxant(TM) (ruboxistaurin mesylate, Lilly) Byetta(R) (exenatide injection,
Survival In Asbestos-Related Cancer Improved By Chemo Combination - Feb 13, 2007 Medical News Today (press release),In the study, patients receiving pemetrexed and cisplatin - along with the vitamin supplements folic acid and B12 - survived nearly three months longer than
Chemo combination improves survival in asbestos-related cancer - Feb 10, 2007 Hindu,This press release issued by the EurekAlert says that in the study, patients receiving pemetrexed and cisplatin — along with the vitamin supplements folic
Scotland rejects Pfizer's Sutent but backs Novartis' Exjade - Feb 13, 2007 Pharma Times (subscription),The SMC also rejected Sanofi-Aventis' obesity drug Acomplia (rimonabant) and Eli Lilly's Alimta (pemetrexed) for non-small cell lung cancer.
Funding can depend on where you live - Feb 5, 2007 ic Wales,...potential use of drugs which are new to the market, are relatively high cost and are awaiting Nice appraisal – for example pemetrexed for mesothelioma.
Cymbalta is bright spot as charges batter Lilly net income - Feb 1, 2007 Pharma Times (subscription),Cancer drug Gemzar (gemcitabine) was up 5% at $371.3 million and down 3% in the USA, while sales of lung cancer treatment Alimta (pemetrexed) increased 26%
Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ... - Jan 31, 2007 Earthtimes.orgActos(R) (pioglitazone hydrochloride, Takeda), Takeda Alimta(R) (pemetrexed, Lilly) Byetta(R) (exenatide injection, Amylin Pharmaceuticals) Cialis(R)
Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and ... - Jan 31, 2007 Yahoo! News (press release)Actos® (pioglitazone hydrochloride, Takeda), Takeda Alimta® (pemetrexed, Lilly) Byetta® (exenatide injection, Amylin Pharmaceuticals) Cialis® (tadalafil,
Point Therapeutics Announces Finalization of Data from Phase 2 Non ... - Dec 22, 2006 PipelineReview.com (press release),..."In our Phase 3 non-small cell lung cancer trials with either docetaxel or pemetrexed, PFS is the primary endpoint and survival is a secondary endpoint.
Point Therapeutics (POTP) Announces Finalization of Data from ... - Dec 21, 2006 StreetInsider.com (subscription),The second trial evaluates the combination of talabostat with pemetrexed versus placebo and pemetrexed. The primary study endpoint is progression-free
Health watchdog reconsiders advice on asbestos cancer drug - Dec 20, 2006 Yorkshire Post Today,The appeal panel of the National Institute for Health and Clinical Excellence (Nice) partially upheld an appeal over the use of pemetrexed disodium (Alimta)
Human Genome Sciences Reports Substantial Progress Toward ... - Jan 8, 2007 Drug Newswire (press release),...in patients with advanced solid tumors to evaluate its safety and tolerability in combination with gemcitabine, pemetrexed, doxorubicin, or FOLFIRI.
MNC pharma firms eyeing duty relief - Dec 27, 2006 Business Standard,For instance, Eli Lilly is known to have requested custom duty exemption for anti-cancer drug Pemetrexed powder combination.
Point Therapeutics Announces Finalization of Data from Phase 2 Non ... - Dec 22, 2006 PipelineReview.com (press release),..."In our Phase 3 non-small cell lung cancer trials with either docetaxel or pemetrexed, PFS is the primary endpoint and survival is a secondary endpoint.
NATCO announces launch of Pemnat (pemetrexed) - Nov 27, 2006 Moneycontrol.com (press release),Hyderabad based NATCO Pharma Limited has announced the launch of Pemetrexed (under the brand name of Pemnat - a 20 ml. vial injection).
Point Therapeutics (POTP) Announces Finalization of Data from ... - Dec 21, 2006 StreetInsider.com (subscription),The second trial evaluates the combination of talabostat with pemetrexed versus placebo and pemetrexed. The primary study endpoint is progression-free
Clinical Trials Update: Dec. 18, 2006 - Dec 18, 2006 Washington Post,The purpose of this study is to compare the effect and safety of an investigational drug with pemetrexed in the second or third line treatment of advanced
Health watchdog reconsiders advice on asbestos cancer drug - Dec 20, 2006 Yorkshire Post Today,The appeal panel of the National Institute for Health and Clinical Excellence (Nice) partially upheld an appeal over the use of pemetrexed disodium (Alimta)
Oncology Drug Pemnat Launched By NATCO - Nov 28, 2006 MedIndia,Natco Pharma Ltd, based in Hyderabad, India, has announced the launch of a generic version of Pemetrexed a drug used to treat certain types of lung cancer.
Natco launches generic of oncology drug - Nov 27, 2006 Economic Times,HYDERABAD: Hyderabad-based Natco Pharma Ltd has launched a generic version of the oncology drug Pemetrexed. While Natco's brand Pemnat would be available at
Natco launches Pemnet - Nov 28, 2006 Andhra Cafe,The drug also finds useful in the treatment of malignant pleural mesothelioma in cases where curative surgery cannot be done,Pemetrexed shows improved
Natco launches Pemnet for non-small cell lung cancer - Nov 26, 2006 Myiris.com,Also useful in the treatment of malignant pleural mesothelioma in cases where curative surgery cannot be done, Pemetrexed is credited with improved survival
Effects of Antifolate Drugs on the Cellular Uptake of Radiofolates ... - Nov 30, 2006 Journal of Nuclear Medicine (subscription)...we wanted to stimulate -FR expression or transport through coapplication of the antifolates methotrexate (MTX), raltitrexed (RTX), and pemetrexed (PMX).
Lilly Delivers Promising Update to Wall Street on Strategic ... - Dec 7, 2006 Yahoo! News (press release)AIR® (Alkermes, Inc.) Alimta® (pemetrexed disodium, Lilly) Byetta® (exenatide injection, Amylin Pharmaceuticals) Cialis® (tadalafil, ICOS), Lilly ICOS LLC
Lilly Delivers Promising Update to Wall Street on Strategic ... - Dec 7, 2006 PR Newswire (press release),AIR(R) (Alkermes, Inc.) Alimta(R) (pemetrexed disodium, Lilly) Byetta(R) (exenatide injection, Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS),
Point Therapeutics Reports Third Quarter 2006 Financial Results 09 Nov 2006 ...without talabostat. The second Phase 3 trial evaluates pemetrexed (Alimta ® ; Eli Lilly) with and without talabostat. Both trials ... -Business Wire (press release),
Lilly Launches Phase III 'GALES' Trial Of ALIMTA(R) (Pemetrexed ... Oct 21, 2006 Eli Lilly and Company has launched a major clinical trial evaluating ALIMTA (pemetrexed for injection) in extensive-stage small cell lung cancer (SCLC), a ... -Medical News Today (press release),
Bevacizumab Plus Either Chemotherapy or Erlotinib Shows Potential ... Nov 8, 2006 ...humanised, antivascular endothelial growth factor (VEGF) monoclonal antibody bevacizumab in combination with either docetaxel or pemetrexed, against the ... -DG News
Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed ... Oct 20, 2006 20 /PRNewswire-FirstCall/ -- Eli Lilly and Company has launched a major clinical trial evaluating ALIMTA (pemetrexed for injection) in extensive-stage small ... -Earthtimes.org
FDA Safety Changes: Daytrana, Oncaspar, Alimta Nov 3, 2006 ...thrombotic events in patients receiving pegaspargase therapy; and dose-limiting myelosuppression in patients receiving treatment with pemetrexed injection. ... -Medscape (subscription)
Eli Lilly Reveals Launch Of GALES Trial Of ALIMTA In Extensive ... Oct 20, 2006 ...(LLY | charts | news | PowerRating) announced that it launched the phase III of the major clinical trial evaluating ALIMTA or pemetrexed for injection in ... -Trading Markets,
Coley Pharmaceutical Group Reports Third Quarter and Nine-month ... Nov 2, 2006 ...evaluate the clinical effectiveness and safety of combining PF-3512676 with Avastin(R) (bevacizumab), Tarceva(R) (erlotinib) or Alimta(R) (pemetrexed) for first ... -Earthtimes.org
Alimta® Safe and Active in Small Cell Lung Cancer Oct 27, 2006 According to results recently published in the Journal of Clinical Oncology, the addition of the chemotherapy agent Alimta® (pemetrexed) to either Platinol ... -Cancer Consultants (press release),
EntreMed Commences Clinical Trial For MKC-1 In Lung Cancer ... Oct 26, 2006 Phase 1 portion of this study will be to assess the safety and maximum tolerated dose of MKC-1 when administered orally in combination with pemetrexed (Alimta(R ... -Medical News Today (press release),
IASLC: Avastin and Tarceva May Be Winning Duo in Second-Line NSCLC Oct 30, 2006 Randomization was on a 1:1:1 basis to Taxotere (docetaxel) or Alimta (pemetrexed) plus placebo, versus Taxotere or Alimta plus Avastin, versus Avastin plus ... -MedPage Today,
Pharmacyclics Reports First Quarter Financial Results Oct 26, 2006 ...line systemic treatment of patients with NSCLC: one in combination with Taxotere® (docetaxel) and one in combination with Alimta® (pemetrexed); and one trial ... -Yahoo! News (press release)
Pharmacyclics Reports First Quarter Financial Results Oct 26, 2006 ...line systemic treatment of patients with NSCLC: one in combination with Taxotere(R) (docetaxel) and one in combination with Alimta(R) (pemetrexed); and one ... -PR Newswire (press release),
(PRN) - Pogo Producing Company to Review Third Quarter 2006 ... Oct 20, 2006 ...(PRN) - Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer ... [+. PRN) - ProLogis ... -Bolsamania.com,
Union supports call for reinstatement of anti-asbestos drug Oct 17, 2006 The protestors, including GMB union members, are calling for primary care trusts (PCTs) to fund the chemotherapy agent Alimta (pemetrexed disodium) for the ... -PersonnelToday.com,
Human Genome Sciences Reports Significant Progress and Outlines ... Oct 9, 2006 ...an open-label, dose-escalation Phase 1B trial of HGS-ETR2 to evaluate its safety and tolerability in combination with gemcitabine, pemetrexed, doxorubicin, or ... -Drug Newswire (press release),
Alimta® Safe and Active in Small Cell Lung Cancer Oct 24, 2006 Researchers involved in a multicenter randomized phase II trial have reported that Alimta® (pemetrexed) and either Platinol® (cisplatin) or Paraplatin ... -Cancer Consultants (press release),
Talabostat Phase 2 Non-Small Cell Lung Cancer Trial Featured at ... Sep 18, 2006 The second trial evaluates talabostat in combination with pemetrexed (Alimta(R); Eli Lilly) versus pemetrexed with placebo. Docetaxel ... -Business Wire
Oncology Researchers Recognized as Heroes of Chemistry Sep 11, 2006 D., led a long-standing collaboration between Eli Lilly and Company and Princeton University that resulted in the compound ALIMTA(R) (pemetrexed for injection ... -PR Newswire
Taiwan-born chemist to receive top award Sep 9, 2006 Chuan Shih, who has been one of the researchers in the pemetrexed disodium development project jointly conducted by Eli Lilly and Princeton University for 10 ... -China Post
Court awards compensation to include chemotherapy not available on ... Sep 14, 2006 Mr Dahele had received Pemetrexed (Alimta) and Cisplatin chemotherapy at St Bartholomew’s Hospital, London but had been told by his treating consultant Dr ... -Response Source
Mesothelioma Reseaerch Shows Promise Aug 26, 2006 The anti-metabolite that has been studied the most is Alimta® (pemetrexed) which has been combined with Platinol producing results superior to Platinol alone. ... -World Fitness
Honors For Medical, Green Chemistry Breakthroughs Go To "Heroes Of ... Aug 30, 2006 Eli Lilly and Co., Indianapolis, Ind., in collaboration with Princeton University, developed ALIMTA, A® (pemetrexed) a chemotherapy drug for patients with ... -Medical News Today
DOH:Further Action Taken To Tackle Obesity As Minister Announces ... Aug 31, 2006 ...b. Irinotecan (Campto) for adjuvant advanced colorectal cancer (subject to licensing). c. Pemetrexed (Alimta) for non small cell lung cancer. ... -Medical News Today
NICE Welcomes Referral Of New Work Programme Topics, UK Aug 31, 2006 ...erlotinib (Tarceva) for non small cell lung cancer; irinotecan (Campto) for adjuvant advanced colorectal cancer (subject to licensing); pemetrexed (Alimta) for ... -Medical News Today
Research and Markets: Pharma Company Lilly Has Developed a Strong ... Aug 31, 2006 Alimta (pemetrexed disodium) is a multi-targeted antifolate that inhibits several enzymes in the biochemical pathways of folate metabolism, which disturb a ... -PharmaLive.com
Natco launches Pemnet - 12 Dec 2006 Andhra Cafe,The drug also finds useful in the treatment of malignant pleural mesothelioma in cases where curative surgery cannot be done,Pemetrexed shows improved
Effects of Antifolate Drugs on the Cellular Uptake of Radiofolates ... - 12 Dec 2006 Journal of Nuclear Medicine (subscription)...we wanted to stimulate -FR expression or transport through coapplication of the antifolates methotrexate (MTX), raltitrexed (RTX), and pemetrexed (PMX).
Natco announces launch of Pemnat (Pemetrexed) for treatment of non ... - Nov 30, 2006 Equity Bulls,Natco Pharma Ltd has announced the launch of Pemetrexed (under the brand name of Pemnat - a 20 ml. vial injection). This is useful in the treatment of
NATCO announces launch of Pemnat (pemetrexed) - Nov 27, 2006 Moneycontrol.com (press release),Hyderabad based NATCO Pharma Limited has announced the launch of Pemetrexed (under the brand name of Pemnat - a 20 ml. vial injection).
Oncology Drug Pemnat Launched By NATCO - Nov 28, 2006 MedIndia,Natco Pharma Ltd, based in Hyderabad, India, has announced the launch of a generic version of Pemetrexed a drug used to treat certain types of lung cancer.
Natco launches generic of oncology drug - Nov 28, 2006 Therapeutics Daily (subscription) (press release),HYDERABAD: Hyderabad-based Natco Pharma Ltd has launched a generic version of the oncology drug Pemetrexed. While Natco's brand Pemnat would be available at
Natco launches Pemnet for non-small cell lung cancer - Nov 26, 2006 Myiris.com,Also useful in the treatment of malignant pleural mesothelioma in cases where curative surgery cannot be done, Pemetrexed is credited with improved survival
Patients denied access to cancer drug - Nov 13, 2006 Life Style Extra,NICE said it was currently appraising the use of Tarceva and another drug pemetrexed (Alimta) for the treatment of non-small-cell lung cancer and the draft
Lilly Delivers Promising Update to Wall Street on Strategic ... - Dec 8, 2006 Yahoo! News (press release)AIR® (Alkermes, Inc.) Alimta® (pemetrexed disodium, Lilly) Byetta® (exenatide injection, Amylin Pharmaceuticals) Cialis® (tadalafil, ICOS), Lilly ICOS LLC
Lilly Delivers Promising Update to Wall Street on Strategic ... - Dec 7, 2006 PR Newswire (press release),AIR(R) (Alkermes, Inc.) Alimta(R) (pemetrexed disodium, Lilly) Byetta(R) (exenatide injection, Amylin Pharmaceuticals) Cialis(R) (tadalafil, ICOS),
Watchdog rules against new treatment for lung cancer - Nov 13, 2006 Guardian Unlimited,Health and Clinical Excellence (Nice) ruled out Tarceva, also known as erlotinib, as well as a second drug, Alimta (pemetrexed), on the grounds of cost.
'Heroes of Chemistry' honored for medical, green chemistry ... 29 Aug 2006 Eli Lilly and Co., Indianapolis, Ind., in collaboration with Princeton University, developed ALIMTA, ® (pemetrexed) a chemotherapy drug for patients with ... -EurekAlert
Pharmacyclics Reports Fourth Quarter and Fiscal 2006 Financial ... Aug 24, 2006 ...for second-line systemic treatment of patients with NSCLC: one in combination with Taxotere(R) (docetaxel) and one in combination with Alimta(R) (pemetrexed). ... -MSN Money
FDA Sends Lilly Letter Regarding Alimta Patient Brochure Aug 1, 2006 The Division of Drug Marketing, Advertising, and Communications (DDMAC) has reviewed a patient brochure (PM-38460) for Alimta® pemetrexed for injection ... -PharmaLive.com
Ulster may be deprived of asbestos cancer drug Aug 18, 2006 The health spokeswoman said: "NICE is carrying out a technology appraisal of the drug pemetrexed disodium (brand name Alimta) for the treatment of malignant ... -Belfast Telegraph
Alimta® Alone or with Platinol® Benefits Patients with Recurrent ... Aug 3, 2006 According to results recently published in the Journal of Thoracic Oncology, treatment with the chemotherapy agent Alimta® (pemetrexed) with or without the ... -Cancer Consultants
Ulster May Be Deprived of Asbestos Cancer Drug Aug 18, 2006 ...drug would not be published for a few months.The health spokeswoman said: "NICE is carrying out a technology appraisal of the drug pemetrexed disodium (brand ... -International News Service
Coley Pharmaceutical Group Reports Second Quarter and Six-month ... Aug 9, 2006 II clinical trials evaluating PF-3512676 for the second-line treatment of NSCLC in combination with Tarceva(R) (erlotinib), with Alimta(R) (pemetrexed), and as ... -PR Newswire
Point Therapeutics Reports Second Quarter 2006 Financial Results ... Aug 8, 2006 The second randomized Phase 3 trial is studying pemetrexed (Alimta(R); Eli Lilly) with and without talabostat. Both trials continue to accrue patients. ... -Business Wire
New drug to aid SA fight against asbestos-linked cancer May 4, 2006 However, the South African Medicines Control Council (MCC) recently approved the registration of a new drug, called Almita (Pemetrexed), developed by ... - Mining Weekly
Point Therapeutics Reports First Quarter 2006 Financial Results ... May 9, 2006 ...a second Phase 3 clinical trial in metastatic non-small cell lung cancer (NSCLC) to evaluate talabostat in combination with pemetrexed versus pemetrexed with ... - Genetic Engineering News
Coley Pharmaceutical Group Reports First Quarter Financial Results May 11, 2006 NSCLC. Each study will combine PF-3512676 with either Avastin(R) (bevacizumab), Erbitux(R) (erlotinib) or Alimta(R) (pemetrexed). ... - PR Newswire
Millennium Achieves First Quarter 2006 Non-GAAP Profitability and ... Apr 27, 2006 ...of VELCADE in non-small cell lung cancer (NSCLC) with the initiation of a three-arm, randomized, Phase II study of VELCADE and pemetrexed in patients with ... - Yahoo! News
Lilly Reports Q1 EPS of $.77, or 13% Growth Apr 20, 2006 Actos(R) (pioglitazone hydrochloride, Takeda), Takeda Alimta(R) (pemetrexed, Lilly) Arxxant(TM) (ruboxistaurin mesylate, Lilly) Byetta(R) (exenatide injection ... - MSN Money
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|